(+)-SJ733
|
|
(1R,3'S,6'R,8a'R)-6''-amino-3-(cyanomethyl)-3'-(hydroxymethyl)-2'',5'-dioxo-2,2',3,3',8',8a'-hexahydro-5'H,7'H-dispiro[indene-1,1'-indolizine-6',3''-indoline]-3-carbonitrile |
|
(2S,3S,4R)-1-(cyclopentanecarbonyl)-4-(hydroxymethyl)-3-[2-(4-methoxyphenyl)phenyl]azetidine-2-carbonitrile
|
|
(3aR)-8-chloro-N-(5-chloropyridin-3-yl)-4-methyl-1,5-dioxo-1,2,3,4,5,9b-hexahydro-3aH-cyclopenta[c]isoquinoline-3a-carboxamide |
|
(3S,4S)-N-(3-Cyano-4-fluorophenyl)-1-oxo-3-(3-pyridinyl)-2-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydro-4-isoquinolinecarboxamide
|
|
(8R,9S,10S)-10-[(dimethylamino)methyl]-N-(4-methoxyphenyl)-9-[4-(2-phenylethynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
|
|
(E)-3-(furan-2-ylmethyl)-8-methoxy-6-(prop-1-en-1-yl)-3,4-dihydro-2H-benzo[e][1,3]oxazine |
|
4-cyano-3-methylisoquinoline
|
|
5',7-Dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-indol]-2'-ol
|
|
5',7-Dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-indol]-2'-ol [
|
|
5-bromo-3'-(4-chlorophenyl)-5′-phenyl-3′H-spiro[indoline-3,2'- [1,3,4]oxadiazol]-2-one |
|
cipargamin
|
|
C-linked phenyl butenonyl c-glycosides with ureidyl, thioureidyl, and sulfonamidyl moieties |
|
Cyclopiazonic acid
|
|
cyclosporin A
|
|
Essentiality, suggested target
|
|
Gnf-pf4492
|
|
KAE609
|
|
KAF246
|
|
Mls000116597
|
|
MMV000642
|
|
MMV000653
|
|
MMV000662
|
|
MMV000848
|
|
MMV006427
|
|
MMV006429
|
|
MMV007617
|
|
MMV007978
|
|
MMV009063
|
|
MMV011567
|
|
MMV019017
|
|
MMV020660
|
|
MMV396633
|
|
MMV396715
|
|
MMV396719
|
|
MMV396749
|
|
MMV665796
|
|
MMV665800
|
|
MMV665803
|
|
MMV665826
|
|
MMV665857
|
|
MMV665878
|
|
MMV665890
|
|
MMV665918
|
|
N-(4-(4-chloro-2-fluorophenyl)-1,3-dimethyl-1H-pyrazol5-yl)-2-(2-isopropyl-1H-benzo[d]imidazol-1-yl)acetamid |
|
Naproxen
|
|
NITD139 |
|
Nitd246
|
|
Nitd609
|
|
Omeprazole
|
|
PA21A092 |
|
SJ733
|
|
Spiroindolone |
|
Spirotetrahydro-β–carbolines |
|
Vanadate
|
|